BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform
BD has launched a new, fully automated high-throughput diagnostic system automating infectious disease molecular testing.
Read MorePosted by Chris Wolski | Aug 25, 2021 | Molecular Diagnostics |
BD has launched a new, fully automated high-throughput diagnostic system automating infectious disease molecular testing.
Read MorePosted by Chris Wolski | Aug 24, 2021 | Uncategorized |
Researchers at SANKEN, Osaka University have demonstrated a method of releasing DNA at the point of measurement.
Read MorePosted by Chris Wolski | Aug 24, 2021 | Unknown Origin & Other Cancer Types |
Siemens Healthineers’ Enhanced Liver Fibrosis (ELF) Test was granted marketing authorization under the De Novo review pathway.
Read MorePosted by Chris Wolski | Aug 13, 2021 | Tissue Processing, Unknown Origin & Other Cancer Types |
Exact Sciences Corp. announced that the performance of its Oncoguard Liver liquid biopsy test is...
Read MorePosted by Chris Wolski | Aug 11, 2021 | Covid 19 |
AditxtScore for COVID-19 is being offered in Great Lakes Medical Laboratory (GLML) locations to monitor and evaluate their COVID-19 immune response.
Read More